RNU7-172P

Across TCGA pan-cancer cohorts, RNU7-172P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RNU7-172P data layer.

The strongest signal is observed in rectum adenocarcinoma (READ), where higher RNU7-172P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-172P expression acts as an unfavorable survival marker, although some lineages such as LAML and STAD show a favorable association.

READ, LUSC, and PAAD are the cancer types where RNU7-172P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
READ	DFS	Tertile	All	0.082	0.820	<.001	72	view →
LUSC	OS	Tertile	All	0.209	0.764	<.001	48	view →
PAAD	OS	Tertile	All	0.210	0.497	.021	45	view →
LAML	DFS	Tertile	All	0.708	0.320	.001	30	view →
COAD	DFS	Tertile	IV	0.176	0.502	.017	18	view →
LUAD	OS	Tertile	II,III,IV	0.266	0.749	.027	18	view →
OV	DFS	Tertile	II,III,IV	0.436	0.553	.030	12	view →
STAD	DFS	Tertile	IV	0.825	0.307	.047	12	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RNU7-172P–READ (DFS)

Open the READ breakdown →